Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liposarcoma × cabazitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 43 Neoplasm Metastasis 10 Recurrence 7 Neoplasms 7 Prostate Cancer Metastatic 6 Breast Neoplasms 5 Neoplastic Cells, Circulating 3 Metastatic Castration-resistant Prostate Cancer 3 Carcinoma, Transitional Cell 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms, Castration-Resistant 2 Ovarian Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Thrombocytosis 1 Solid Cancer 1 Prostate Cancer, Hereditary, 7 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Penile Neoplasms 1 Pancreatic Neoplasms 1 Nonseminomatous germ cell tumor 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Neoplasms 1

Interventions

Doxorubicin 20 Trabectedin 10 Radiotherapy 10 Ifosfamide 10 pazopanib 5 Gemcitabine 5 ribociclib 4 Specimen Handling 4 Docetaxel 4 Biopsy 4 selinexor 3 pembrolizumab 3 palbociclib 3 eribulin 3 X-Rays 3 Filgrastim 3 Cyclophosphamide 3 temsirolimus 2 pegfilgrastim 2 liposomal doxorubicin 2 cixutumumab 2 brostallicin 2 brigimadlin 2 belinostat 2 avelumab 2 abemaciclib 2 Vincristine 2 Temozolomide 2 Surgical Procedures, Operative 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01913652 2021-09-14

Ph II Cabazitaxel DD Liposarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡